2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Spinal Cord Neoplasms
1
Neurofibrosarcoma
1
Neurofibroma
1
Nerve Sheath Neoplasms
1
Interventions
Doxorubicin
17
Ifosfamide
12
Radiotherapy
8
pazopanib
5
selinexor
4
pembrolizumab
4
Filgrastim
4
pegfilgrastim
3
Sirolimus
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Imatinib Mesylate
3
Etoposide
3
AZD 6244
3
fludarabine phosphate
2
brostallicin
2
X-Rays
2
Trabectedin
2
Specimen Handling
2
Sorafenib
2
Radiation Dose Hypofractionation
2
Radiation
2
Diathermy
2
Chemotherapy, Adjuvant
2
Biopsy
2
thymoglobulin
1
temsirolimus
1
tazemetostat
1
sotigalimab
1
sapanisertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
Neurofibromin 1
×
Clear all
NCT01567787
2017-02-10
NF01
University of Florida
Phase NA
Withdrawn